Genvec is based out of Gaithersburg. Develops and commercializes novel therapies that produce medically beneficial proteins at the site of disease. The company applies its gene based technologies to create product candidates, such as TNFerade for the treatment of cancer, and BIOBYPASS, to treat severe coronary artery disease.Whalewisdom has at least 1 13G filings, and 106 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2010-01-28. The notice included securities offered of Equity
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
GENVEC INC65 W WATKINS MILL RD
GAITHERSBURG MD 20878
Business Phone: 2406320740
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS
2834-PHARMACEUTICAL PREPARATIONS